- ANZ Breast Cancer Trials Group Limited
- File Size
- 117.95 MB
- Release Date
- 2018-07-29 10:52:14
- Version Updated Date
- 2018-07-29 10:52:14
- Catalan, Valencian
- Dutch, Flemish
- Moldovan, Moldavian, Romanian
- Spanish, Castilian
- Minimum iOS Version 10.0 - iPhone5 - iPadFourthGen - iPadFourthGen4G - iPhone5c - iPhone5s - iPadAir - iPadAirCellular - iPadMiniRetina - iPadMiniRetinaCellular - iPhone6 - iPhone6Plus - iPadAir2 - iPadAir2Cellular - iPadMini3 - iPadMini3Cellular - iPodTouchSixthGen - iPhone6s - iPhone6sPlus - iPadMini4 - iPadMini4Cellular - iPadPro - iPadProCellular - iPadPro97 - iPadPro97Cellular - iPhoneSE - iPhone7 - iPhone7Plus - iPad611 - iPad612 - iPad71 - iPad72 - iPad73 - iPad74 - iPhone8 - iPhone8Plus - iPhoneX - iPad75 - iPad76 - iPhoneXS - iPhoneXSMax - iPhoneXR - iPad812 - iPad834 - iPad856 - iPad878 - iPadMini5 - iPadMini5Cellular - iPadAir3 - iPadAir3Cellular
The 40th Annual Scientific Meeting of Breast Cancer Trials (BCT) will be held from 25-27 July 2018 at The Westin Sydney.
The full and extensive program will include two days of scientific sessions covering timely reviews of breast cancer clinical trials, discussion of new protocols, future clinical trials research and other research developments. Delegates include leading Australian and New Zealand medical practitioners and clinicians, and clinical trials management personnel, as well as international guest speakers.
The ASM is an opportunity for breast cancer researchers throughout Australia and New Zealand to learn of recent advances in breast cancer research worldwide; to share knowledge and research outcomes; and to collaborate, plan and strategise for new breast cancer clinical trials research initiatives.
More information about the ASM including registration is available at www.bct2018.org
Breast Cancer Trials (BCT) is the largest independent, oncology clinical trials research group in Australia and New Zealand. For 40 years, Breast Cancer Trials has conducted clinical trials for the treatment, prevention and cure of breast cancer.
The research program involves multicentre national and international clinical trials and brings together over 800 researchers in 90 institutions throughout Australia and New Zealand. BCT has contributed to more than 1,030 peer-reviewed publications and more than 14,000 women have participated in BCT clinical trials.
To find out more about our research program and fundraising activities, visit www.breastcancertrials.org.au